The side effect duration varies from person to person, and usually disappears after 5 to 10 days of stopping the medication, depending on the individual’s metabolic status, the severity of the disease and the dosage of the medication, so it is recommended to follow the doctor’s instructions. Recombinant Human Granulocyte Stimulating Factor (RHGF) is indicated for the treatment of neutropenia caused by cancer chemotherapy, myelodysplastic syndromes, aplastic anemia, congenital and idiopathic neutropenia. The side effects of recombinant human granulocyte stimulating factor also include the phenomenon of musculoskeletal system such as bone pain, lumbago, chest pain, very few people will experience shock, interstitial pneumonitis, adult respiratory distress syndrome, increase in naïve cells, etc.; severe hepatic, renal, cardiac and pulmonary dysfunction is contraindicated; pediatric patients should be used with caution. Patients who need to use recombinant human granulocyte stimulating factor, please under the guidance of a professional doctor reasonable use of medication.